Algeria vs IDA blend: Cause of death, by non-communicable diseases, female
Algeria
79.9%
in 2021
IDA blend
44.6%
in 2021
Algeria rank
42nd
IDA blend rank
39th
Cause of death, by non-communicable diseases, female over time
- Algeria
- IDA blend
How they compare
Algeria currently reports 79.9% against 44.6% in IDA blend, a difference of 35.3%.
That makes Algeria's figure about 1.8 times IDA blend's.
Across all 6 years both countries report, Algeria has been ahead every year.
Algeria ranks 42nd and IDA blend ranks 39th of 185 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | IDA blend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.8% | 29.1% | 43.7% | Algeria |
| 2010s | 81.4% | 41.0% | 40.4% | Algeria |
| 2020s | 75.7% | 44.6% | 31.1% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Algeria or IDA blend?
- Algeria, at 79.9% against 44.6% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Algeria and IDA blend?
- 35.3%, with Algeria ahead.
- How many years of comparable data are there for Algeria and IDA blend?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and IDA blend rank globally for cause of death, by non-communicable diseases, female?
- Algeria ranks 42nd and IDA blend ranks 39th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.